GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ZYUS Life Sciences Corp (OTCPK:ZLSCF) » Definitions » Land And Improvements

ZLSCF (ZYUS Life Sciences) Land And Improvements : $0.00 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ZYUS Life Sciences Land And Improvements?

ZYUS Life Sciences's land and improvements for the quarter that ended in Sep. 2024 was $0.00 Mil.

ZYUS Life Sciences's annual land and improvements increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.65 Mil) and increased from Dec. 2022 ($0.65 Mil) to Dec. 2023 ($0.66 Mil).


ZYUS Life Sciences Land And Improvements Historical Data

The historical data trend for ZYUS Life Sciences's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZYUS Life Sciences Land And Improvements Chart

ZYUS Life Sciences Annual Data
Trend Dec21 Dec22 Dec23
Land And Improvements
- 0.65 0.66

ZYUS Life Sciences Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - 0.66 - - -

ZYUS Life Sciences Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.


ZYUS Life Sciences Business Description

Traded in Other Exchanges
Address
407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is primarily engaged in the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates. It is a licensed producer and distributor of medical cannabis for both medical and adult recreational access in Canada.

ZYUS Life Sciences Headlines

No Headlines